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RESUMO:
Este trabalho contempla uma breve revisão da literatura, empregando os periódicos das bases 
de dados Scielo, Sciencedirect e ACS, sobre os métodos mais utilizados para síntese do anel 
1,2,4-oxadiazólico, destacando suas vantagens e desvantagens. Foi realizada também uma 
pesquisa sobre as principais funções deste grupamento, sua ação no tratamento de doenças, 
os testes realizados para a confirmação das ações farmacológicas e os resultados obtidos.
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ABSTRACT:
This work includes a brief literature review, using the periodicals of the Scielo, 
Sciencedirect and ACS databases, about the most used methods for the synthesis of 
1,2,4-oxadiazole ring, highlighting their advantages and disadvantages. It was also 
done a search in the literature about the main functions of this group, its action in the 
treatment of diseases, the tests made for the confirmation of the pharmacological 
actions and the results obtained.
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1. INTRODUCTION
Organic chemistry is very important for drugs synthesis, because it allows us to 
build molecules from the simplest to the most complex. This area of organic chemistry 
presents some essential features, such as the development of a sequence of synthetic 
steps, the concern about good yields and the rate of purity of the product. At this point, 
we can differentiate the drugs of other organic products such as insecticides, pesticides 
and dyes, for example, as drugs show a high degree of purity directly linked to the 
synthetic methodology and to the quality of raw materials and of intermediates involved 
in the synthesis , mainly because many drugs may not be administered in racemic form.
According to Menegatti et al. (2001), drugs of synthetic origin represent a 
significant quota of the pharmaceutical market and when we analyze the structure of 
these drugs, it is observed that 62% of them are heterocyclic, of these, 95% have 
nitrogen and 18% have the oxygen atoms in their structure.
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There are many heterocyclic compounds with pharmacological activities 
found in the literature, such as acridines, pyrazolones, pyrazoles, imidazoles, 
oxazolidines, pyridines and thiazolines. Among these the oxadiazoles are among the 
most cited in the literature.
This family of compounds is structurally characterized by a heterocyclic ring of 
5 members containing two nitrogen atoms and one oxygen atom. Depending on the 
positions of these atoms in the heterocyclic nucleus it can be described four isomeric 
structures represented in Figure 1 (ROSA, 1992).
Figure 1: oxadiazole heterocycle isomers.
The isomers 1,3,4- and 1,2,4-oxadiazole are the most studied, because they 
give the best pharmacological results. Its metabolic profile and the ability to engage in 
hydrogen bonds give the oxadiazole a bioisosteric relationship with amides and esters 
(SANTOS FILHO, 2002). Because of the importance of their biological activities, 
significant progress has been observed in the synthesis of new oxadiazoles aiming to 
produce analgesics, antispasmodics and anti-inflammatories (SRIVASTAVA et al., 
2003).
The 1,2,4- oxadiazole nucleus is also used as esters and amides bioisosters in 
biological studies. This unit is present in muscarinic agonists drugs (MACOR et al., 
1996), in serotonergic (antidepressant) and in drugs antagonists (SWAIN et al., 1991; 
WIEDER-WELLS et al., 2004).
The synthesis and the evaluation of several derivatives of the group in question, 
where the affinity by muscarinic receptors is strong, puts them among the possible drugs 
for the treatment of Alzheimer´s disease (ORLEK et al., 1991).
This way, it came the interest in conducting a bibliography review on the group 
1,2,4-oxadiazole in order to collect information about its use in pharmacology and about 
the methods employed in its synthesis.
2. METHODOLOGY
This research was done employing literature databases, such as Scielo, 
Sciencedirect and ACS, using as keywords 1,2,4-oxadiazole, synthesis and 
pharmacology. The papers, written in Portuguese or English languages, were selected 
from the last twenty years, except those of historical importance.
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3 . MATERIAL  AND METHODS
3.1 - Methods of synthesis
The 1,2,4-oxadiazole are heterocyclic substances very important and comprise a 
large class of compounds that have vast amount of available information in the 
literature, not only about its synthesis as well as about its pharmacological activity.
The first method of preparing this compound was described by Tiemann and 
Kruger in 1884 and consisted of reacting an amidoxime with an acyl chloride, warming 
the reaction beyond the amidoxime melting point to promote the coupling of the two 
substrates and subsequent cyclization (Scheme 1).
Scheme 1: Oxadiazole synthetic route done by Tieman and Krüger in 1884.
This method, although very used, has some disadvantages. Among these 
stand out: low income, long reaction time (6 -12h), difficult purification and formation of 
byproducts, such as oxadiazole resulting from amidoxime cyclization.
Gangloff et al. (2001) reported the use of tetrabutylammonium fluoride (TBAF) 
as a very efficient catalyst in the cyclization step of the intermediate O-acylated 
(Scheme 2). According to the authors the reaction occurs under mild conditions of 
temperature, especially when using one equivalent of TBAF and THF or acetonitrile as 
solvent. The use of less polar solvents like dichloromethane did not result in the product 
formation, what helps previous studies about the strongly basic behavior of fluoride ions 
in polar aprotic solvents (BARTSCH, 1970). The use of weaker bases such as pyridine, 
require heating so that the reaction can occur. The authors also report that the presence 
of substituents at the orto positions of aromatic groups present in the 5 position of the 
heterocyclic ring tend to increase the reaction time.
Scheme 2 - Reaction scheme proposed by GANGLOFF et al.
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Alternative methods suggest the use of esters in the place of the acyl chlorides 
can be found in the literature. These methods require the presence of strong bases such 
as NaH or NaOEt, heating at reflux temperature in THF or EtOH and typically provide 
low yields. According to Durden and Heywood (1971) the reaction of esters with 
amidoximes can be governed by the same factors that governs the basic hydrolysis of 
the esters, or the electrophilicity of the carbonyl group and the basicity of the group that 
is being displaced. Simple esters of dichloroacetic and trichloroacetic acids react like 
amidoximes in a direct way to form 1,2,4-oxadiazole , while esters of aliphatic acids do 
not generate product in an appreciable form. Still according to the authors the use of 
vinyl or allyl acetates with acetamidoxime is a particularly useful method for obtaining a 
direct form 3,5-dimethyl-1 ,2,4-oxadiazole (Scheme 3).
Scheme 3: General scheme of synthesis to obtain 1,2,4-oxadiazole from esters.
Recent studies (AMARASINGHE et al., 2006) show that the use of methyl and 
ethyl esters and salts, such as K CO  or Ce CO  under reflux conditions in toluene , 
2 3 2 3
provide oxadiazole in good yield (Scheme 4) since these salts after its dissolution in the 
medium, act as very efficient bases in the step of cyclodehydration . The authors also 
reported the selective regarding to the alcohol structure used to obtain the ester. In the 
reaction of methyl succinate and t-butyl with acetamidoxime in the reaction conditions, 
only the methyl moiety reacts, remaining the t-butyl group intact.
Scheme 4: General scheme for the synthesis of 1,2,4-oxadiazole proposed by 
AMARASINGHE et al.
This method also showed to be very effective for the synthesis of the bis-
oxadiazole structures from esters of malonic acid with yields ranging from good to 
reasonable (Scheme 5).
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Scheme 5 - General scheme of synthesis of bis-oxadiazole catalyzed by K CO .
2 3
Sharma et al. (2009) synthesized 20 oxadiazole derivatives from long chain 
carboxylic acids in the form of esters or acyl chlorides in the presence of K CO  as a 
2 3
catalyst (Scheme 6). In the used methodology the authors mixed the solubilized 
amidoxime in toluene with the carboxylic derivative (ester or acyl chloride), and then 
adding K CO  and the mixture remained under reflux for 6 to 12 hours with stirring. The 
2 3
acyl chlorides used were prepared in situ, since they are not commercially available, and 
the excess of thionyl chloride was removed by distillation before the adding of 
amidoxime. The authors compared the yields obtained when using esters or acyl 
chlorides, with the use of these last ones, in general, have provided the best yields (70-
79%) and shorter reaction times (1,2-2,5 h).
Scheme 6 - General scheme for the synthesis of 1,2,4-oxadiazole proposed by SHARMA et al.
Methods that employ reagents that act as activators of the carboxylic group 
(SURESHBABU et al., 2008) such as 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide 
(EDC), dicyclohexylcarbodiimide (DCC ), 1,1'-carbonyldiimidazole (CDI), O-
(benzotriazole-1-il), N,N,N',N'-tetramethyluronium-tetrafluoroborate (TBTU) and the 
Burgess reagent has been widely used in exhaustive reflux conditions with DMF or 
pyridine, to facilitate obtaining the 1,2,4-oxadiazole by O-acylation, in a one step 
process. These agents aims to facilitate the purification of the oxadiazole products by 
simple liquid-liquid extraction or filtration.
Recent studies (AUGUSTINE et al., 2009) show the use of propylphosphonic 
®
anhydride (T3P ) as a new route of direct conversion of carboxylic acids into 1,2,4-
oxadiazole (Scheme 7). This method consists on the reaction of a carboxylic acid with 
®
an amidoxime in the presence of T3P  as an activating agent of the carboxylic group, 
triethanolamine (TEA) and ethyl acetate (EtOAc) as the solvent. The authors employed 
a variety of aliphatic and aromatic carboxylic acids, and the obtained yields range from 
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87 to 97%, independent on the functional present group in the alkyl/aryl structures.  
Methods using mixtures of solvents, such as EtOAc-DMF, allowed that the reactions 
o
would be realized at higher temperatures (110 C) decreasing the reaction time without 
affecting the yield of the reaction.
®
Scheme 7: Schematic of reaction using T3P  to obtain 1,2,4-oxadiazole.
®
T3P  makes only water soluble byproducts, is less toxic and the method is very 
simple. Furthermore, this method does not require the initial conversion of carboxylic 
acids in their corresponding acid chlorides or esters.
Kaboudin and Malekzadeh (2011) recently reported the synthesis of 14 
oxadiazole derivatives reacting with amidoxime with an acid anhydride in an aqueous 
medium under reflux of 12h in the absence of catalysts (Scheme 8), with yields ranging 
from poor to excellent (35-93%) (Table 1).
Scheme 8 – Reactional scheme proposed by Kaboudin and Malekzadeh (2011)
TABLE 1 – Substituents and yields obtained by Kaboudin and Malekzadeh (2011)
.
w R ’ Y ie ld  (% ) 
/ 6H 5 / 6H 5      
ǿ -C lC 6H 4 C 6H 5 60  
p-B rC 6H 4 C 6H 5 81  
2 ,4-C l2C 6H 3 C 6H 5 52  
m -C lC 6H 4 C 6H 5 85  
p-M eOC 6H 4 C 6H 5 69  
Cyclohexy l C 6H 5 86  
C 6H 5 p -CH 3C 6H 4 81  
2 ,4-C l2C 6H 3 p -CH 3C 6H 4 72  
p-B rC 6H 4 p -CH 3C 6H 4 76  
C 6H 5 n -C 5H 11 53  
2 ,4-C l2C 6H 3 n -C 5H 11 40  
m -C lC 6H 4 n -C 5H 11 35  
p-B rC 6H 4 n -C 5H 11 48  
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Another synthetic approach to obtain the oxadiazole ring is the 1,3-dipolar 
cycloaddition of nitrile oxides to nitriles (RAJAGOPALAN, 1969; QUADRELLI et al., 
1997). This is an advantageous way due to the easy synthetic access to the raw 
materials by its commercial availability, but the low reactivity of triple bond of the nitrile 
becomes the reaction less favorable. This way, the cycloaddition 1,3-dipolar of nitrile to 
nitrile oxides non-activated occurs only under conditions of vigorous reaction when the 
formation of 1,2,4-oxadiazole competes with dimerization of nitrile oxides unstable to 
provide 1,2,5-oxadiazole-2-oxide (furoxan) or 1,2,4-oxadiazole-4 -oxide (Figure 2). The 
activation of the nitrile group (CN) can be obtained by the introducing of electron 
acceptor groups linked to the nitrile carbon (BOKACH et al., 2003).
FIGURE 2: Structural formulas of (a) 1,2,5-oxadiazole-2-oxide and (b) 1,2,4-
oxadiazole-4-oxide.
An emerging method for obtaining the 1,2,4-oxadiazole derivatives is the 
application of microwave irradiation (MW). This technology became popular among 
synthetic organic chemists to improve classical organic reactions by obtaining better 
yields in shorter reaction times (BOUGRIN et al., 2003).
th
Since the last two decades of the 20  century, there is an increasing demand for 
the development of sustainable chemistry in order to minimize the large amount of 
waste and the consecutive treatment. One of the major contributions to this volume of 
waste are the components used as the volatile solvent in the synthesis steps of 
sequential purification of the desired compound. The use of solvents in organic 
synthesis reactions have been classified as essential due to its role in facilitating the 
transfer of heat from the reaction mixture with the neighborhood, promoting the diffusion 
of molecules along to the reaction bottle, and reduced of the difficulty of transfers 
between reactant and product. However, it is known that the reactions can occur in the 
solid phase, being in the most of the cases more selective (due to organized crystalline 
structure), and more efficient than in the liquid phase reactions (CANDEIAS et al., 2009).
The use of these reactions has several advantages in comparison with classical 
conditions (BOUGRIN et al., 2003):
Ÿ reducing the inherent risks to the use of large amounts of volatile organic 
solvents;
Ÿ it´s not needed to recover, purify and reuse the solvent, reducing this way the 
arising pollution from these operations;
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Ÿ  in the most of the cases, the desired products are in sufficient purity to avoid 
the chromatography or even recrystallization, simplifying synthetic steps.
Ÿ  faster reaction can be completed within 1 to 10 minutes;
Ÿ  procedure economically attractive to the industry due to the non-used of 
solvent and less trappings necessary.
The conventional method for O-acylation of an amidoxime using an acid 
chloride in the presence of a coupling reagent generally do not provide appreciable 
yields under MW conditions. However, the same reaction in the presence of ammonium 
fluoride supported on alumina, is obtained 1,2,4-oxadiazole with good yields in only 3 
minutes under MW irradiation (KABOUDIN;SAADATI, 2005).
Scheme 9 – Reaction conditions used by KABOUDIN and SAADATI (2005) 
TABLE 2 – Substituents and yields obtained by KABOUDIN and SAADATI (2005) 
FREITAS et al. (2007) related the reaction of methyl levulinate with amidoxime 
in the presence of potassium carbonate in MW conditions for the synthesis of 1,2,4-
oxadiazole (Scheme 10). The obtained yields were higher than those obtained by the 
conventional method and the reaction times were approximately 5-10 min, against a 
reaction time of 18 h by the classical method. The synthetic methodology employed 
consisted not only in the solely in a mortar milling of methyl levulinate, the appropriated 
amidoxime and K CO . Then the mixture was transferred to a test tube and was 
2 3
irradiated in a home microwave oven for 10 minutes using 100% of the equipment power 
(650 W). After cooling, the content was chromatographed on silica gel using AcOEt-
hexane as eluent.
R R’ Yield (%) R R’ Yield (%) 
C6H5 C6H5 90 C6H5 p-MeOC6H4 78 
p-ClC6H4CH2 C6H5    2,4-Cl2C6H3 p-MeOC6H4 71 
p-ClC6H4 C6H5 87 p-ClC6H4CH2 p-NO2C6H4 80 
2,4-Cl2C6H3 C6H5 75 p-ClC6H4 p-NO2C6H4 86 
C6H11 C6H5 85 C6H11 p-NO2C6H4 82 
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Scheme 10: Reaction scheme to the synthesis of 1,2,4-oxadiazole proposed by 
FREITAS et al. (2007)
KABOUDIN and SAADATI (2007) proposed a method in a single step based on 
the reaction of nitrile with hydroxylamine hydrochloride in the presence of sodium 
carbonate supported on magnesium oxide, followed by the reaction with acyl halides 
(Scheme 11). In this method, initially hydroxylamine hydrochloride, sodium carbonate 
and the magnesium oxide are intimately mixed in a mortar until to obtain finely and 
homogeneous dust. In sequence is added the nitrile, and the mixture is stirred for 5 
minutes and then irradiated for 5 minutes (180 W). To the formed product is added to the 
acyl chloride and the reaction mixture is irradiated for 2-5 minutes at 600 W. By this 
method 12 derivatives were synthesized 1,2,4-oxadiazoles with reasonable yields (40 
to 70%).
Scheme 11 - Reaction scheme to obtain 1,2,4- oxadiazole proposed by KABOUDIN 
and SAADATI (2005)
ADIB et al. (2006) obtained 12 oxadiazole derivatives in only one step without 
the use of activated derivatives of carboxylic acids. The synthesis of the intermediate 
amidoxime is done by MW, having acetic acid as catalyst, in a fast process (1 minute). 
The aldehyde is added in sequence and the mixture is irradiated by microwave during 3 
minutes to obtain the oxadiazole with excellent yields (92-97%) (Scheme 12). 
Mechanistically the process passes by the formation of an intermediate 4,5-dihydro-
1,2,4-oxadiazole (oxadiazoline) that undergoes the oxidation in the reaction conditions.
Scheme 12 - Reaction scheme for the synthesis of 1,2,4-oxadiazole proposed by ADIB 
et al. (2006)
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Recently it was published in the literature a synthetic procedure using irradiation 
by ultrasound (USI) in the synthesis of oxadiazole (BRETANHA et al., 2011). In this work 
the authors report the synthesis of 12 oxadiazole derivatives containing the 
trichloromethyl group in the position 3 and different alkyl and aryl groups in the position 5 
obtained by the reaction of trichloroacetamidoxime with the appropriated acyl chloride  
(Scheme 13). It was done the comparison in terms of time and performance of the 
conventional process (in reflux with different solvents) against the USI process, having 
ethyl acetate as solvent. In all experiments using the conventional process were spent 
20 hours and the yields ranged from 60 to 90%, while for the USI process were spent 15 
minutes and the yields ranged from 84 to 98 %, showing the potential use of this 
technique in the synthesis of these heterocycles.
Scheme 13 – Reaction scheme propose by BRETANHA et al. (2011).
TABLE 3 – Substituents and yields obtained by BRETANHA et al. (2011) [27]
The chemistry of the 1,2,4-oxadiazole has been re-examined many times along 
the years. Derivatives heterocyclic of nitrogen and oxygen in positions 1,2,4 are 
important from synthetic interest viewpoint because they represent an important class of 
natural and unnatural products, many of which present biological activities. The basic 
concept behind these developments is that the 1,2,4-oxadiazole ring is a bioisosteric 
alternative of hydrolysis resistant to one molecule of ester or amide [20], and one better 
performance in vivo is often observed due to the metabolic stability of the oxadiazole ring 
in the aqueous medium within the complete range of pH to the climate temperature 
(ISPIKOUDI et al., 2010).
R Yield (%) R Yield (%)
C H
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92 o-IC H
6 4
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p-MeC H
6 4
93 Me 86
p-NO C H
2 6 4
94 Et 90
o-FC H
6 4
95 CH Cl
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6 4
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6 4
96 CCl
3
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The bioisosteric replacement of an amide portion represents a center focus  
because of its implications in peptide chemistry and development of peptidomimetics, 
which are being explored in large part to contour some of the disadvantages of native 
peptides and to increase the bioavailability and potency of drugs based on peptide, 
furthermore, the core 1,2,4-oxadiazole is the structural core unit of the muscarinic 
agonist (DUCHET et al., 2010).
4. PHARMACOLOGICAL ACTIVITIES
Some derivatives of 1,2,4-oxadiazole have analgesic effects, anti-inflammatory 
and anti-cancer and show high efficacy as agonists and antagonists for different 
receptors.
4.1 Anti-inflammatory activity
Inflammation is a complex phenomenon involving relation of humoral and 
cellular responses through a series of inflammatory mediators. It is an usual symptom 
covering different pathologies (KONTOGIORGIS; HADJIPAVLOU-LITINA, 2005). The 
acute inflammatory reaction is characterized by arteriolar dilation, increasing of vascular 
permeability, leukocyte accumulation and pain. The inflammation can be caused by 
physical, chemical or biological, agents causing disturbances in the cell membrane, 
causing the activation of phospholipase A2 and liberation of arachidonic acid and its 
metabolites, PAF-acether (Platelet Activating Factor) and lysosomal enzymes (SAKAE 
et al., 2005).
An anti-inflammatory agent is that one which reduces or prevents one or more 
components of the inflammatory reaction. The pharmacological control of the 
inflammation can be exercised in two ways: by antagonizing or inhibiting the liberation of 
inflammatory mediators responsible for the triggering or amplification of the 
inflammatory reaction, or acting directly on the inflammatory cells (KOROLKOVAS; 
BURCKHALTER, 2005).
The most widely used method to evaluate the anti-inflammatory is to test the 
ability of compounds in study in the reduction of edema in the rat´s hind paw caused by 
injection of an inflammatory agent such as carrageenan.
FAROOQUI et al. (2009) tested the anti-inflammatory activity of 15 different 
1,2,4-oxadiazole-3,5-disubstituted derivatives (Table 4) in mice with inflammation 
induced carrageenan.
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TABLE 4: Anti-inflammatory activity of 1,2,4-oxadiazole-3,5-disubstituted. 
(1a-o)
The anti-inflammatory activity of the synthesized compounds is connected to 
the molecular basic structure skeleton. The compound 1a exhibited great power but 
problably the presence of one or more lipophilic substituents on the aromatic ring further 
increase the activity. The compound 1j is the most powerful and has two methoxy groups 
 
! cHN
N
O
N R
O
Compounds R % Inflamation inhibition 
1a OH 75,34 ±3,4 
1b Aniline 34,24 ±4,7 
1c m-anisidine 35,61 ±4,5 
1d o-anisidine 87,67 ±1,6 
1e p-anisidine 49,31 ±4,2 
1f o-fluoroaniline 67,12 ±7,3 
1g p-fluoroaniline 64,38 ±5 
1h 2,4-fluoroaniline 52,05 ±6,7 
1i 3-fluoro-4-methoxyaniline  60,27 ±7,3 
1j 3,4-dimethoxyaniline 95,89 ±1,9 
1k m-toludine 16,43 ±5,7 
1l 4-trifluoromethylaniline 36,98 ±5,7 
1m 3-ethynylaniline 84,93 ±1,6 
1n Pyridine 87,67 ±1,9 
1o Benzylamine 76,71 ±6,2 
Control Control 0 
Reference Diclofenac 50,68 ±9 
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at positions orto and para comparing with just one methoxy substituent present in the 
compound 1d, revealing the importance of electron donating groups in the orto and para 
positions on the aromatic ring.
Derivatives 3-aryl-5-decapentil-1,2,4-oxadiazole (2a-f) (Figure 3) also showed 
anti-inflammatory activity (BEZERRA et al., 2000)
FIGURE 3: Derivatives of 3-aril-5-decapentil-1,2,4-oxadiazole.
The oxadiazole 2a, 2e and 2f reduced the induced edema by carrageenan in 
mice in 29, 33 and 34%, respectively. The compounds 2b, 2c and 2d, which have 
substituents on the aromatic ring respectively in orto, meta and para positions showed a 
reduction of the edema from 55, 67 and 67%, respectively. In addition, the anti-
inflammatory effect of the compounds 2c and 2d was comparable with aspirin (68%) and 
ibuprofen (73 %). The compounds with decapentil group in C5 of 1,2,4-oxadiazole have 
higher anti-inflammatory activity , because the compounds with longer hydrocarbon 
chains are able to enter in cells more quickly, and leave more slowly than those with 
shorter chains, due to its increased hydrophobicity , or perhaps, the smaller molecules , 
such as isopropyl group at C5, for example, are excreted more rapidly.
Some 1,2,4-oxadiazole peptidomimetic (Figure 4) were also tested for their anti-
inflammatory activity by Leite et al. (2000).
FIGURE 4: Derivatives of 1,2,4-oxadiazole tested by LEITE et al. (2000)
The compounds 3a, 3b, 3c, 3d, 3f and 3g significantly inhibited the induced 
edema by carrageenan in rat´s paw, depending on the dose employed. The compound 
3e, at a dosage of 3mg/kg, did not showed any noticeable inhibitory effect on the edema 
induced by carrageenan. Higher doses of this derivative have not been studied since 
they cause toxic effects in animals with death in about 1 minute after administration. Oral 
administration of the compounds 3a, 3c and 3g was completely ineffective in inhibiting 
the edema at all observed periods.
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The pharmacological results demonstrate that compounds 3a, 3c and 3g, when 
administered intravenously, are anti-edematous. However, when administered orally do 
not modify the edema induced by carrageenan, what suggests its inability to be 
absorbed or possible destruction by digestive enzymes.
4.2 - Anti-cancer activity
Many classes of anticancer drugs were developed, however, most of the drugs 
cause side effects due to lack of specificity of tumor and its multidrug.
The main factors that contribute to cancer cell survival are: the variation in the 
metabolism because make them able to survive in conditions of very low oxygen and 
this what they take an important selective advantage over normal cells, the difficulty of 
drug absorption in the target tissues and tumor location.
Some chemotherapeutic agents lose their effectiveness after prolonged 
exposure, because the cells become resistant to the drugs. Therefore, the synthesis of 
new and effective anti-cancer agents becomes necessary.
The 1,2,4-oxadiazole were also tested on their anti-cancer activity. In 2009, 
Kumar et al. (2009) have synthesized and tested the activity of 14 derivatives of 1,2,4-
oxadiazole-3,5-disubstituted (Table 5) against cell lines of prostate cancer (PC3, 
DU145 and LNCaP), breast (MCF7 and MDA231), colon (HCT116) and pancreas 
(PaCa2).
TABLE 5: 1,2,4-oxadiazole tested for anti-cancer activity.
R'
R
N
O
N
R"
 
4a-n 
Compounds R R’ R” 
4a H H p-FC6H4 
4b H H Pyridine-4-il 
4c OCH3 OBn Pyridine-4-il 
4d OC5H9 OCH3 C6H5 
4e OC5H9 OCH3 p-FC6H4 
4f OC5H9 OCH3 p-ClC6H4 
4g OC5H9 OCH3 p-HOC6H4 
4h OC5H9 OCH3 Pyridine-4-il 
4i OC5H9 OCH3 Pyridine-3-il 
4j OC5H9 OCH3 (Indol-3-il) 
methyl 
4k OC5H9 OCH3 CH2COCH3 
4l OH OCH3 p-FC6H4 
4m OC5H9 OCH3 Pyrrolidine-2-il 
4n OC5H9 OCH3 Pyrrolidine-4-il 
 
 144
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
The positions of substitution at C3 and C5 of the nucleus 1,2,4-oxadiazole 
played an important role in anti-cancer function. The radical R", at the C5 position is 
responsible for providing the to the potency and specificity compound. When R = H or 
OH or when R'= H or OBn is observed the decrease in the potency of the compound. 
Some compounds were highly effective and exhibit specificity for certain cell type in 
relation to the other.
The compounds 4a and 4b showed weak inhibitory activity against cancer lines 
tested. The substitution by the groups 3'-cyclopentyloxy and 4'-methoxy in the aryl ring 
of the position C3, respectively (4e and 4h), increase the activity in relation to 4a and 4b. 
However, a larger group such as OBz (4c) at the position R 'is detrimental to the activity. 
The compound 4g showed to be a potent cytotoxic agent against the various cancer cell 
lines tested. The compounds 4f, 4h, 4j, 4k, 4n show selectivity against cell lines of 
pancreatic cancer. The compound 4m exhibited high selectivity and high effectiveness 
against cell lines of prostate cancer. The substituents at the C3 and C5 positions of the 
ring 1,2,4-oxadiazole showed to be vital for the potency, suggesting specific interactions 
with biological targets of these groups .
Khatik et al. (2012) synthetized and tested against prostate cancer cells (DU-
145) some sulfide and sulfonyl derivatives of 1,2,4-oxadiazole nucleus. Six of them 
showed good activity, with IC  values ranging from 0.5 to 5.1 mM, against androgen 
50
independent cells (PC-3), and low cytotoxicity on non-cancerous cells (MCF-10A).
4.2.1  Activity proapoptotic
The apoptosis is the programmed cell destruction. It occurs in an organized 
form and, different from the necrosis, requires energy for its execution. It can be caused 
by a pathological stimulus, such as a DNA damage, for example. When the damage 
caused to DNA is greater than the cell's ability to reverse it, it is safer for the organism 
that the cell death program is activated by radioactive stimuli, chemical or viral, because 
the failure of apoptosis can benefit the multiplication of a mutant cell originating tumors. 
The discovery of small molecules able to selectively induce apoptosis in cancer cells 
through a variety of mechanisms represents an attractive prospect for the future 
treatment of cancer.
Recent researches show the proapoptotic action of 1,2,4-oxadiazole based in 
the indole ring (ZIEDAN et al., 2010). The table 6 shows the oxadiazole compounds (5a-
v) tested for proapoptotic action.
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TABLE 6: 3,5-disubstituted oxadiazole based on the indole ring structure. 
The anti-tumor effect in vitro of the compounds 5a-v was evaluated against a 
panel of cancer cell lines of different human tissues , including colon (COLO 320), 
pancreatic (MiaPaCa -2), breast (MCF -7) and peripheral blood of a patient with 
leukemia of T-cell. In general, the cell lines of colon and pancreas were the most 
sensitive to the indol-oxadiazole and the exposure of the cells to the compounds 
resulted in a decrease (dependent on the dose) of the cell viability with about 50% of 
inhibition in the micromolar concentration range. The most active compounds in the  
colon (5n and 5u) were less active compared with diaryl-oxadiazole. However, the other 
compounds of the present series showed a low inhibition index in micromolar 
concentration, on strains of pancreatic cancer, breast cancer and leukemia T cells, 
where the diaryl-oxadiazole was taken as inactive.
Tests with strain H9c2 of the heart of muscle cells (characterized by a high 
abundance of mitochondria) showed selectivity in the most of the cases. Through 
studies of relation between the structure and indol-oxadiazole activity, it is noted that in 
certain compounds that have one nitrogen in the indole ring is substituted (R'= H) and a 
phenyl substituent in R (5g and 5h) were able to induce the cell death by apoptosis in the 
cell strains of colon and pancreas, while the compounds 5e and 5k, structurally related, 
induced the apoptosis only in colon cells.
Still analyzing the relation between structure and activity of the compounds, the 
data clearly demonstrated that the both electron withdrawing groups (eg, R'= NO , 5n) 
2
and electron donating groups (R' = OMe, compounds 5I and 5s) are tolerated in the 
position 5 of the indole ring with respect to the power cell lines of colon and pancreas. 
The effect of specific R' in relation to different substituents is difficult to determine, 
because compounds related to the same group R' give quite different results. For 
example, the compound 5u is the most active of the series on colon and pancreas 
lineages, while the 5o, its closer analogue, is among the least actives.
For most of the compounds in the series, the nitrogen of the indole ring is  without 
N
O
N
R
N
R'
R"
 
5a-v 
 R R’ R”  R R’ R” 
5a CH3 H H 5l p-ClC6H5 OCH3 H 
5b CH3 OCH3 H 5m p-ClC6H5 F H 
5c CH3 F H 5n p-ClC6H5 NO2 H 
5d CH3 Cl H 5o p-ClC6H5 Cl H 
5e C6H5 H H 5p p-ClC6H5 Cl CH3 
5f C6H5 OCH3 H 5q p-OCH3C6H5 H H 
5g C6H5 OH H 5r p-OCH3C6H5 H CH3 
5h C6H5 F H 5s p-OCH3C6H5 OCH3 H 
5i C6H5 NO2 H 5t p-OCH3C6H5 F H 
5j C6H5 Cl H 5u p-OCH3C6H5 Cl H 
5k p-ClC6H5 H H 5v NH2 H H 
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substituent, except 5p and 5r (where R' = Me), which were among the least active in the 
series. This suggests that the substitution radical Me in the indole nitrogen decreases 
the activity of the compound.
Some of the tested compounds, especially 5l, 5n and 5t, were active in 
apoptosis promoting through the activation of the caspase -3 and 7 (responsible for 
cleaving protein substrates of the cell), or by a caspase independent pathway, 
depending on the type of the cell and the compound studied. The cell necrosis was 
induced by the compound 5u and this type of cell death may also be interpreted by the 
toxic effects which other compounds may cause to the cells. These results are relevant 
considering that the development of mechanisms resistant to apoptosis confer high 
survival capacity and low drug sensitivity of tumor cells.
4.3  Anticonvulsant activity
Studies to obtain more information about the anticonvulsant action of this class 
of compounds have also been carried out because, in spite of the development of 
several anticonvulsants, the epilepsy treatment still remains insufficient. About a third of 
the patients do not answer well to the treatments currently available (GUILHOTO et al., 
2007).
The best known mechanisms that result in anticonvulsant activity are the 
potentiation of GABA (γ-aminobutyric acid) and the lock of the sodium channel (Lankau 
et al., 2007).
Three trial models, the MES test, PTZ test and the rotarod were used in rats by 
Lankau et al. (2007) to obtain the characterization of primary compounds and a first clue 
to the effectiveness and safety of 1,2,4-oxadiazole synthesized (Table 7).
TABLE 7: 3-aryl and 5-aryl-1 ,2,4-oxadiazole.
N
N
O
Het
R
 
6a-i 
N
O
N
Het
R
 
7a-f 
Com pounds Heterocycle  R  Com pounds Heterocycle  R  
6a 1-Im idazolyl H  7ª 1-[1,2,4]Triazol H  
6b 1-Im idazolyl 4-C l 7b 1-[1,2,4]Triazol 2-F 
6c 1-[1,2,4]Triazol H  7c 1-[1,2,4]Triazol 3-F 
6d 1-[1,2,4]Triazol 4-C l 7d 1-[1,2,4]Triazol 4-F 
6e 1-[1,2,4]Triazol 2-F 7e 1-[1,2,4]Triazol 3-CH 3 
6f 1-[1,2,4]Triazol 3-F 7f 1-[1,2,4]Triazol 4-C l 
6g 1-[1,2,4]Triazol 3-CH 3    
6h 1-[1,2,4]Triazol 4-CH 3    
6i 
5- Methyl-1-
[1,2,4]triazol 
3-F    
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All synthesized compounds with in vivo activity, potentiated the induced GABA 
currents in rat cortical neurons, however, without interaction with the benzodiazepine 
site, which is usually expected for this positive modulation. This indicates that the 
compounds modulate GABA reception by a different link site.
The compounds 6b, 6d and 6g also acted as potent blockers of the sodium 
channels. A combination of both mechanisms in a molecule may be a new approach to 
develop a potent anticonvulsant.
In summary, the results indicate that both oxadiazole acting as sodium channel 
blockers or selective enhancers to GABA have efficacy in the anticonvulsant activity. 
The tested substances are better tolerated than the benzodiazepines.
4.4 - Anti-HIV Activity
The epidemic of the Acquired Immunodeficiency Syndrome (AIDS) is a 
worldwide public health problem. Currently there are millions of infected people with HIV 
virus, its causative agent.
The effective therapeutic agents developed to combat the progression of AIDS 
an based on four groups of drugs: (1) nucleoside transcriptase reverse (NRTIs), (2) 
inhibitors not nucleoside of reverse transcriptase (NNRTIs), (3) protease inhibitors (PI) 
and (4) fusion inhibitors. Efforts are concentrated on the search for new molecules with 
anti-HIV activity, focus on the development of NNRTIs, because this class has 
advantage to be minimally toxic and inhibit HIV through an allosteric mechanism, which 
changes the three-dimensional structure of the enzyme active site, not allowing their 
reaction, anymore in spite of having significant problems with the resistance 
development (DOLBIER et al., 1999).
The alkenyldiarilmethanes (ADAMs) are a class of non-nucleoside inhibitors.  
However, the potential utility of ADAMs is limited for the presence of labile metabolically 
methyl esters which are hydrolyzed by unspecific esterases present in the blood  
plasma, resulting in the formation of inactive metabolites of carboxylic acid. In order to 
discoverer an ADAM metabolically stable, Sakamoto et al. (2007) synthesized and 
tested ADAM shown in Figure 5, in which the system was incorporating 1,2,4-
oxadiazole.
Figure 5: ADAM incorporating the system 1,2,4-oxadiazole.
 
b
O
N
N
O
Me
O
NOMeF
MeO
MeO
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The compound exhibited enhanced metabolic stability in rat plasma, along with 
the ability to inhibit the reverse transcriptase of HIV-1, and the cytopathic effect of HIV-
1RF, and HIV-1IIIB (Different types of HIV have been identified: HIV-1 and HIV-2, and yet 
these two types are divided into groups and subgroups, which shows the great variety 
viral gene ) in submicromolar concentrations..  
4.5 - Antifungal activity 
A set of molecules containing the nucleus 1,2,4-oxadiazole, substituted 1,2,3-
triazole, which also has occupied a central position in medicinal chemistry, and the 
piperidine, present in many bioactive substances have been tested for its ability 
antifungals by Sangshetti et al. (2009).
The synthesized compounds illustrated in Figure 6, were tested for in vitro 
antifungal activity. This activity was evaluated against different fungal strains, such as C. 
albicans, F. oxysporum, A. flavus, A. niger and C. Neoformans, and the values of 
minimum inhibitory concentration (MIC) were determined using the standard method on 
agar plates. The miconazole and fluconazole were used as standard of comparison of 
antifungal activity.
Figure 6: 3-(1-(1-substitutedpiperidine-4-il)-1H-1,2,3-triazole-4-il)-1,2,4-oxadiazole-
5(4H)-ona.
Many of the new synthesized compounds showed good antifungal activity. 
From the data of Table 8, it is found that the compounds 8a and 8h are the most active 
between all the compounds tested against all microorganisms, except for C. 
neoformans. In relation to A. niger, 8h is more potent than miconazole and has its value 
comparable to fluconazole, as shown by the lower MIC. The compound 8a was more 
potent than miconazole against C. albicans (MIC-20) and A. flavus (MIC-10) and 
equipotent with miconazole against F. oxysporum (MIC-25) and A. niger (MIC-12.5).
N
N
N
N
O
N
N
O
R
 
8a-i  
R= 
8a) CH3 8f) COC6H5 
8b) CH2CH3 8g) CO(p-ClC6H4) 
8c) COCH3 8h) SO2CH3 
8d) COCH2CH3 8i) SO2(p- CH3C6H4) 
8e) COC3H7 8j) H 
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TABLE 8: Antifungal activity of the synthesized compounds (MIC (µg/mL)).
The substitutions on piperidine nitrogen caused different results in relation to 
the activity of the molecule. It is observed that the methyl substituent (8a) increases the 
molecule activity when compared to the structure without substituent (8j). However the 
increase of the alkyl chain (8b) or the introduction of the acetyl group (8c) causes the 
decrease of the antifungal activity. The substitution for acyl groups with longer alkyl 
chains (propionyl -8d and butyryl-8e) cause greater loss of activity, and the replacement 
for the benzoyl group either takes to an increase of the activity when compared to 8c and 
8d.
However, the introduction of the mesyl group in the same piperidine nitrogen 
provided the most active compound of the series (8h). This compound is more potent 
than miconazole against C. albicans (MIC-20) and A. niger (MIC-10) equipotent to 
miconazole against F. oxysporum and equipotent with fluconazole against and A. niger 
(MIC-10).
The authors also found the antifungal activity of the synthetic intermediates (8k) 
and (8l). They observed that the introduction of the nucleus 1,2,4-oxadiazole to triazole 
ring (8l) enhanced the antifungal activity when compared to the activity of the 
intermediates amidoximes (8k) (Scheme 14), indicating the importance of this  
heterocyclic nucleus for the molecule activity.
The results suggest that the series containing 1,2,3-triazoles with nucleus 
1,2,4-oxadiazole and the piperidine ring substituted by the methyl or methylsulfone 
groups in the piperidine nitrogen may serve as important pharmacophores for the 
conception of new anti-fungal agents with potent activity and minimal toxicity.
Compounds C. albicans 
F. 
oxysporum 
A. flavus A. niger C. neoformans 
8a 20 25 10 12,5 60 
8b 37 39 19 19 39 
8c 60 61 31 31 65 
8d 85 90 42 42 85 
8e 90 95 _ _ 85 
8f 85 88 42 42 85 
8g 40 55 20 25 40 
8h 20 25 15 10 27,5 
8i 30 33 25 20 40 
Miconazole 25 25 12,5 12,5 25 
Fluconazole 5 5 5 10 5 
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Scheme 14 – Structures of the compounds evaluatted proposed by SANGSHETTI et  
al. (2009)
4.6 Other activities
Another application for this heterocycle is the prevention of the pro-depressant 
effect of L-arginine. Studies have demonstrated that L-arginine, an amino acid 
precursor of nitric oxide, has a dual effect (antidepressant and pro-depressant) in the 
forced swimming test.
 
In 2007, Ergun et al. tested [1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-ona] 
(ODQ - Figure 7) for this purpose realizing Porsolt's test (forced swimming test). The 
results showed that doses of ODQ (3 and 10mg/kg) canceled the pro-depressant effect 
of L-arginine (300 and 1000mg/kg), while anti-depressant component produced by 100 
mg/kg L-arginine was not affected.
Figure 7 – Structural formula of ODQ
According to Bignami (2015), the orphan drugs' are medical products intended 
for the prevention diagnosis, or treatment of serious diseases or that constitute a risk to 
life and are rare. These medications are designated as "orphans" because in normal 
market conditions, the pharmaceutical industry has little interest in the development and 
commercialization of products targeted for the small number of patients affected by rare 
d i s e a s e s ,  s u c h  a s  D u c h e n n e  m u s c u l a r  d y s t r o p h y,  b e c a u s e  t h e
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On May 27, 2005, the Committee for Orphan Drugs published its favorable 
opinion for orphan designation of the acid 3-[5-(2-fluoro-phenyl)-(1,2,4-oxadiazole- 3-
il)]- benzoic for the treatment of Duchenne muscular dystrophy (EUROPEAN 
MEDICINES AGENCY, 2015) [46]. This is a genetic neuromuscular disease 
characterized by a progressive and irreversible weakness of the skeletal muscles, 
leading the patient to severe respiratory difficulty and death (FONSECA et al., 2007). 
The 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-il]-benzoic acid, produced by PTC 
Therapeutics (2015) and known commercially in Europe as Translarna (Figure 8), is a 
drug which may surpass a specific type of abnormality present in the dystrophin gene of 
some Duchenne patients. Therefore, it could allow the production of functional 
dystrophin protein in muscle cells of this group of patients.
®
Figure 8 - Structural formula of Ataluren
There are still other useful applications of this group that were not cited in this 
work, including plant protection (ROHR, 1989; JESCHKE et al., 1995), use as crystalline 
liquid mesophases (GALLARDO et al., 2011; SHANKER; TSCHIERSKE, 2011), 
OLED's (WU et al., 2005), tracers for Positron Emission Tomography (PET) (BARROW 
et al., 2011), polymers (ROSSER et al., 1981) and optical brighteners, among others 
(PROSSEL et al., 1978), which demonstrates the great versatility of this family of 
compounds.
5. FINAL CONSIDERATIONS
As can be observed, there are many efficient ways to obtain 1,2,4-oxadiazole. 
Besides the methods mentioned here, with more research is still possible to find in the 
literature different ways to achieve the heterocycle in question. Searches of other 
synthetic routes are important, because they aim the search of reagents and reaction 
conditions more efficient.
The fact of the oxadiazole ring is a part of the structural nucleus of the 
muscarinic agonist is an important factor for its efficiency in the use of drugs. The 
pharmacological activity of the groups 1,2,4-oxadiazole depends on the structure of the 
compound. There are still many drugs, whose the activities need to be potentiated and 
untreated diseases that need effective medications for its cure. Therefore, this line of 
research is of paramount importance to the organic medicinal chemistry.
 
b O
N
COOH
F
 152
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
6. REFERENCES
ADIB, M.; JAHROMI, A. H.; TAVOOSI, N.; MAHDAVI, M.; BIJANZADEH, H. R. 
Microwave-assisted efficient, one-pot, three-component synthesis of 3,5-disubstituted 
1,2,4-oxadiazoles under solvent-free conditions. Tetrahedron Lett 2006, 47, 2965. 
AMARASINGHE, K. K. D.; MAIER, M. B., SRIVASTAVA, A.; GRAY, J. L. One-pot 
synthesis of 1,2,4-oxadiazoles from carboxylic acid esters and amidoximes using 
potassium carbonate. Tetrahedron Letters 2006, 47, 3629. 
AUGUSTINE, J. K.;VAIRAPERUMAL, V.; NARASIMHAN, S.; ALAGARSAMY, P.; 
®
RADHAKRISHNAN, A. Propylphosphonic anhydride (T3P ): an efficient reagent for the 
one-pot synthesis of 1,2,4-oxadiazoles, 1,3,4-oxadiazoles and 1,3,4-thiadiazoles. 
Tetrahedron 2009, 65, 9989. 
BARROW, J. C.; HARRISON, S.; MULHEARN, J.; SUR, C.; WILLIAMS, D. L.; 
WOLKENBERG, S. US Patent 0081297 2011.
BARTSCH, R. A. Eliminations from 2-butyl halides induced by halide ions in 
dimethylformamide and dimethyl sulfoxide. J. Org. Chem. 1970, 35, 1023. 
BEZERRA, N. M. M.; OLIVEIRA, S. P.; SRIVASTAVA, R. M.; SILVA, J. R. Synthesis of 3-
aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor 
properties. Il Farmaco 2005, 60, 955. 
BIGNAMI, F. EURORDISES. Disponível em: <http://www.eurordis.org/pt-pt/content/o-
que-e-um-medicamento-orfao> Acess in 19/11/2015. . 
BOKACH, N. A.; ANATOLII V. KHRIPOUN, A. V.; KUKUSHKIN, V. Y.; HAUKKA, M.; 
POMBEIRO, A. J. L. A route to 1,2,4-oxadiazoles and their complexes via platinum-
mediated 1,3-dipolar cycloaddition of nitrile oxides to organonitriles. Inorg. Chem. 2003, 
42, 896.
 
BOUGRIN, K.; LOUPY, A.; SOUFIAOUI, M. Microwave-assisted solvent-free 
heterocyclic synthesis. J. Photochem. Photobiol. C 2005, 6, 139.
BOKACH, N. A.; ANATOLII V. KHRIPOUN, A. V.; KUKUSHKIN, V. Y.; HAUKKA, M.; 
POMBEIRO, A. J. L. A route to 1,2,4-oxadiazoles and their complexes via platinum-
mediated 1,3-dipolar cycloaddition of nitrile oxides to organonitriles. Inorg. Chem. 2003, 
42, 896.
                                                                                                                                                                                                       153
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
BOUGRIN, K.; LOUPY, A.; SOUFIAOUI, M. Microwave-assisted solvent-free 
heterocyclic synthesis. J. Photochem. Photobiol. C 2005, 6, 139.
BRETANHA, L. C.; TEIXEIRA, V. E.; RITTER, M.; SIQUEIRA, G. M.; CUNICO, W.; 
PEREIRA, C. M.P.; FREITAG, R. A. Ultrasound-promoted synthesis of 3-
trichloromethyl-5-alkyl(aryl)-1,2,4-oxadiazoles. Ultrasonics Sonochem. 2011, 18, 704. 
CANDEIAS, N. R.; BRANCO, L. C.; GOIS, P. M.; AFONSO, C. A. M.; TRINDADE, A. F. 
MORE sustainable approaches for the synthesis of N-based heterocycles. Chem. Rev. 
2009, 109, 2703. 
DOLBIER JR., W. R.; BURKHOLDER, C. R.; MÉDEBIELLE, M. J. FLUORINE CHEM. 
1999, 95, 127-130. 
DUCHET, L.; LEGEAY, J. C.; CARRIÈ, D.; PAQUIN, L.; EYNDE, J. J. V.;  BAZUREAU, J. 
P. Synthesis of 3,5-disubstituted 1,2,4-oxadiazoles using ionic liquid-phase organic 
synthesis (IoLIPOS) methodology. Tetrahedron 2010, 66, 986. 
DURDEN JR, J. A.; HEYWOO, D. L. The reaction of “activated” esters with amidoximes. 
A convenient synthesis of 1,2,4-oxadiazoles. J. Org. Chem. 1971, 36, 1306. 
ERGÜN, Y.; ERGÜN, U. G. Ö. Eur. J. Pharmacol. 2007, 554, 150.
E u r o p e a n  M e d i c i n e s  A g e n c y .  D i s p o n í v e l  e m : 
<http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009
/10/WC500005403.pdf>. Acess in 19/11/2015.
FAROOQUI, M.; BORA, R.; PATIL, C. R. Synthesis, analgesic and anti-inflammatory 
activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles. Eur. J. Med. 
Chem. 2009, 44, 794. 
FONSECA, J. G.; MACHADO, M. J. F.; FERRAZ, C. L. M. S. Distrofia muscular de 
Duchenne: complicações respiratórias e seus tratamentos. Rev. Cienc. Med. 2007, 16, 
109. 
FREITAS, J. J. R.; FREITAS, J. C. R.; DA SILVA, L. P.; DE FREITAS, J. R.; KIMURA, G. 
Y. V.; SRIVASTAVA, R. M. Microwave-induced one-pot synthesis of 4-[3-(aryl)-1,2,4-
oxadiazol-5-yl]-butan-2-ones under solvente free conditions. Tetrahedron Letters 2007, 
48, 6195.
154
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
GALLARDO, H.; FERREIRA, M.; VIEIRA, A. A.; WESTPHAL, E.; MOLIN, F.; ECCHER, 
J.; BECHTOLD, I. H. Columnar mesomorphism of bent-rod mesogens containing 1,2,4-
oxadiazole rings. Tetrahedron 2011, 67, 9491.  
GANGLOFF, A. R.; LITVAK, J.; SHELTON, E. J.; SPERANDIO, D.; WANG, V. R.; RICE, 
K. D. Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammoniuum 
fluoride as a mild and efficient catalyst. Tetrahedron Lett. 2001, 42, 1441.
 
GUILHOTO, L. M. F. F.; NOBRE, C.; SILVA, A. R. C. O.; TAVARES, C. Educational 
activities for elementary school teachers on epilepsy in the periphery of São Paulo. J. 
Epilepsy Clin. Neurophysiol. 2007, 13, 143.
ISPIKOUDI, M.; AMVRAZIS, M.; KONTOGIORGIS, C.; KOUMBIS, A. E.; LITINAS, K. 
E.;  LITINA, D. H.; FYLAKTAKIDOU, K. C. Convenient synthesis and biological profile of 
5-amino-substituted 1,2,4-oxadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5635. 
JESCHKE, P.; LINDNER, W.; WACHENDORFF-NEUMANN, U.; ERDELEN, C. BAYER 
Aktiengesellschaft US Patent 5,428,049 1995.
KABOUDIN, B., MALEKZADEH, L. . Organic reactions in water: an efficient method for 
the synthesis of 1,2,4-oxadiazole in water. Tetrahedron Lett. 2011, 52, 6424.
KABOUDIN, B.; SAADATI, F. Magnesia-supported hydroxylamine hydrochloride in the 
presence of sodium carbonate as an efficient reagent for the synthesis of 1,2,4-
oxadiazoles from nitriles.Tetrahedron Letters 2007, 48, 2829. 
KABOUDIN, B.; SAADATI, F. Novel method for the synthesis of 1,2,4-oxadiazoles using 
alumina supported ammonium fluoride under solvent-free condition. J. Heteroc. Chem. 
2005, 42, 699. 
KHATIK, G. L.; KAUR, J.; KUMAR, V.; TIKOO, K.; NAIR, V. A. 1,2,4-oxadiazoles: a new 
class of anti-prostate cancer agents. Bioorg. Med. Chem. Lett. 2012, 22, 1912.
KONTOGIORGIS, C. A.; HADJIPAVLOU-LITINA, D. J. Synthesis and anti-inflammatory 
activity of coumarin derivatives. J. Med. Chem. 2005, 48, 6400. 
KOROLKOVAS, A.; BURCKHALTER, J. H.; Pharmaceutical Chemistry, 1st edition, 
Guanabara-Koogan, Rio de Janeiro, 1988.
                                                                                                                                                                                                      155
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
KUMAR, D.; GAUTAM PATEL, G.; JOHNSON, E. O.; SHAH, K. Synthesis and 
anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Bioorg. Med. Chem. 
Letters 2009, 19, 2739.
LANKAU, H. J.; UNVERFERTH, K.; GRUNWALD, C.; HARTENHAUER, H.; 
HEINECKE, K.; BERNÖSTER, K.; DOST, R.;EGERLAND, U.; RUNDFELDT, C. New 
GABA-modulating 1,2,4-oxadiazole. Eur. J. Med. Chem. 2007, 42, 873. 
LEITE, A. C. L.; VIEIRA, R. F.; FARIA, A. R.; WANDERLEY, A. G.; AFITPOUR, P.; 
XIMENES, E. C. P. A.; SRIVASTAVA, R. M.; OLIVEIRA, C. F.; MEDEIROS, M.V.; 
ANTUNES, E.; BRONDANI, D. J. Synthesis, anti-inflammatory and antimicrobial 
activities of new 1,2,4-oxadiazoles peptideomimetics. Il Farmaco 2000, 55, 719. 
MACOR, J. E.; ORDWAY, T.; SMITH, R. L., VERHOEST, P. R.; MACK, R. A. Synthesis 
and use of 5-vynil-1,2,4-oxadiazoles as Michael acceptors. A rapid synthesis of the 
potent muscarinic agonist L-670,548. J. Org. Chem. 1996, 61, 3228.
MENEGATTI, R.; FRAGA, C. A. M.; BARREIRO, E. J. Quím. Nova Escola (Cadernos 
Temáticos), 2001, n. 3, p. 16-22.
OrLEK , B. S., BLANEY , F. E., BROWN , F., CLARK , M. S. G., HADLEY , M. S., 
HATCHER, J.; RILEY , G. J., ROSENBERG , H. E., WADSWORTH , H. J., WYMAN, P. 
Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic 
receptor. J. Med. Chem. 1991, 34, 2726. 
PROSSEL, G.; SCHINZEL, E.; RÖSCH, G. US Patent 4,122,257 1978. 
PTCBio. Disponível em: http://www.ptcbio.com/en/pipeline/ataluren-translarna/. Acess 
in 19/11/2015.
QUADRELLI, P.; INVERNIZZI, A. G.; FALZONI, M.; CARAMELLA, P. Cycloadditions of 
nitrile oxides to amidoximes. A general synthesis of 3,5-disubstituted 1,2,4-oxadiazole-
4-oxides. Tetrahedron 1997, 53, 1787.
RAJAGOPALAN, P. Dipolar addition reactions of nitrile oxides. VII. A new general 
method of synthesis of 3,5-disubstituted 1,2,4-oxadiazoles. Tetrahedron Lett. 1969, 5, 
311. 
ROHR, O. Ciba-Geigy Corp. US Patent 4,871,685 1989.
156
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
ROSA, M. F. Dissertation in Organic Chemistry (MSc), Federal University of Rio de 
Janeiro, Brazil, 1992.
ROSSER, R. W.; SHALHOUB, I. M.; KWONG, H. US Patent 4,273,918 1981. 
SAKAE, T. M.; BALDISSEROTO, C. M.; BIANCHINI, N. Comparation of Casearia 
silvestris with indometacine and placebo in reducing edema in the hind paw of rats, 
induced by the use of carrageenan. Arq. Catarinenses Med. 2005, 34, 33.
SAKAMOTO, T.; CULLEN, M. D.; HARTMAN, T. L.; WATSON, K. M.; BUCKHEIT, R. W.; 
PANNECOUQUE, C.; CLERCQ, E.; CUSHMAN, M. Synthesis and anti-HIV activity of 
new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase 
inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems. J. 
Med. Chem. 2007, 50, 3314. 
SANGSHETTI, J. N.; NAGAWADE, R. R.; SHINDE, D. B. Synthesis of novel 3-(1-(1-
substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as 
antifungal agent. Bioorg.Med. Chem. Letters 2009, 19, 3564. 
SANTOS FILHO, J. M. S. Bioisoterical planning, synthesis and pharmacological 
evaluation of new anologues of 1,2,4-oxadiazoles. Dissertation in Biotechnology of 
Bioactive Products (MSc), Federal University of Pernambuco, Recife, Brazil, 2002.
SHANKER, G.; TSCHIERSKE, C. Synthesis of non-symmetrically substituted 1,2,4-
oxadiazole derived liquid crystals. Tetrahedron 2011, 67, 8635. 
SHARMA, S.; GANGAL, S.; RAUF, A. An efficient, one-pot synthesis of novel 3,5-
disubstituted-1,2,4-oxadiazoles from long-chain carboxylic acid derivatives. Acta Chim. 
Slov. 2009, 56, 369. 
SRIVASTAVA, R. M.; LIMA, A. A.; VIANA, O. S.; SILVA, M. J. C.; CATANHO, M. T. J. A.; 
MORAIS, J. O. F. Antiinflammatory property of 3-aryl-5-(n-propyl)-1,2,4-oxadiazoles 
and antimicrobial property of 3-aryl-5-(n-propyl)-4,5-dihydro-1,2,4-oxadiazoles: their 
synthesis and spectroscopic studies. Bioorg. Med. Chem. 2003, 11, 1821.
SURESHBABU, V. V.; HEMANTHA, H. P.; NAIK, S. A. Synthesis of 1,2,4-oxadiazole-
linked orthogonally urethane-protected dipeptide mimetics. Tetrahedron Letters, 2008, 
49, 5133. 
                                                                                                                                                                                                      157
 Visão Acadêmica, Curitiba, v.16, n.2, Abr. - Jun./2015 - ISSN 1518-8361
SWAIN, R. B.; KNEEM, C.; MOSELEY, J.; SAUNDERS, J.; SEWARD, E. M.; 
STEVENSON, G.; BEER, M.; STANTON, J.; WATLING, K. Novel 5-HT  antagonists. 
3
Indole oxadiazoles. J. Med. Chem. 1991, 34, 140.
TIEMANN, F.; KRÜGER, P. Ueber amidoxime und azoxime. Chem. Ber. 1884, 17, 1685.
WIEDNER-WELLS, M. A.; HENNINGER, T. C.; FRAGA-SPANO, S. A.; BOGGS, C. M.; 
MATHEIS, M.; RITDHIE, D. M.; ARGENTIERI, D. C.; WATCHER, M. P.; HLASTA, D. J. 
Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-
1,2,4-oxadiazoles, novel classes of small molecule interleukin 8 (IL-8) receptor 
antagonists. Bioorg. Med. Chem. Letters 2004, 14, 4307.
WU, F. I.; SHU, C. F.; CHIEN, C. H.; TAO, Y. T. Fluorene-based oxadiazoles: thermally 
stable electron-transporting materials for light-emitting devices Synth. Metals 2005, 
148, 133.
ZIEDAN, N. I.; STEFANELLI, F.; FOGLI, S.; WESTWELL, A. D. Design, synthesis and 
pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles. Eur. 
J. Med. Chem. 2010, 45, 4523. 
